Ocelot Bio Overview

  • Year Founded
  • 2020

Year Founded

  • Status
  • Out of Business

  • Employees
  • 14

Employees

  • Latest Deal Type
  • Out of Business

Ocelot Bio General Information

Description

Operator of a biopharmaceutical company intended to help patients with severe liver disease. The company's therapeutic peptide selectively addresses portal hypertension-induced complications of end-stage liver disease (ESLD), enabling patients to overcome the serious consequences associated with complications of portal hypertension.

Contact Information

Ownership Status
Out of Business
Financing Status
Formerly VC-backed
Corporate Office
  • 601 Marshall Street
  • Redwood City, CA 94063
  • United States
+1 (858)
Primary Industry
Drug Discovery
Other Industries
Biotechnology
Vertical(s)
Corporate Office
  • 601 Marshall Street
  • Redwood City, CA 94063
  • United States
+1 (858)

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Ocelot Bio Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
3. Out of Business 20-Dec-2024 Completed Out of Business
2. Early Stage VC 12-Jul-2023 Completed Clinical Trials - Phase 2
1. Early Stage VC (Series A) 13-Apr-2021 $36M $36M Completed Clinical Trials - Phase 2
To view Ocelot Bio’s complete valuation and funding history, request access »

Ocelot Bio Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
Series A
To view Ocelot Bio’s complete cap table history, request access »

Ocelot Bio Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Operator of a biopharmaceutical company intended to help patients with severe liver disease. The company's therapeutic p
Drug Discovery
Redwood City, CA
14 As of 2024

Waltham, MA
 

Cambridge, MA
 
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Ocelot Bio Competitors (2)

One of Ocelot Bio’s 2 competitors is Ardelyx, a Formerly VC-backed company based in Waltham, MA.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Ardelyx Formerly VC-backed Waltham, MA
Akebia Therapeutics Formerly VC-backed Cambridge, MA
You’re viewing 2 of 2 competitors. Get the full list »

Ocelot Bio Patents

Ocelot Bio Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
WO-2024073445-A1 Mixed vasopressin receptor agonist-antagonist for modulating mean arterial pressure Inactive 30-Sep-2022
WO-2024073451-A1 Mixed vasopressin receptor agonist-antagonist for treating end-stage liver disease and complications associated thereof Inactive 30-Sep-2022
WO-2023183339-A1 Selective vasopressin receptor agonist for end-stage liver disease Inactive 22-Mar-2022
US-20160122386-A1 V1a receptor agonists Active 05-Nov-2014
US-9388214-B2 V1a receptor agonists Active 05-Nov-2014 C07K7/06
To view Ocelot Bio’s complete patent history, request access »

Ocelot Bio Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Ocelot Bio FAQs

  • When was Ocelot Bio founded?

    Ocelot Bio was founded in 2020.

  • Where is Ocelot Bio headquartered?

    Ocelot Bio is headquartered in Redwood City, CA.

  • What is the size of Ocelot Bio?

    Ocelot Bio has 14 total employees.

  • What industry is Ocelot Bio in?

    Ocelot Bio’s primary industry is Drug Discovery.

  • Is Ocelot Bio a private or public company?

    Ocelot Bio is a Private company.

  • What is Ocelot Bio’s current revenue?

    The current revenue for Ocelot Bio is .

  • How much funding has Ocelot Bio raised over time?

    Ocelot Bio has raised $39M.

  • Who are Ocelot Bio’s competitors?

    Ardelyx and Akebia Therapeutics are competitors of Ocelot Bio.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process